Common mutations at the homocysteine metabolism pathway and pediatric stroke

Thrombosis Research

Volumn 102, Issue 2, 2001, Pages 115-120

  Akar, Nejat ^a,c   Akar, Ece ^a   Özel, Duygu ^a   Deda, Gülhis ^a   Sipahi, Tansu ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Factor V gene; Methionine synthase reductase; Methylene tetrahydrofolate dehydrogenase; Methylene tetrahydrofolate reductase; Pediatric stroke; Prothrombin gene

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; AMINO ACID METABOLISM; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERHOMOCYSTEINEMIA; INFANT; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; THROMBOSIS; TURKEY (REPUBLIC);

ADOLESCENT; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHILD; CHILD, PRESCHOOL; FACTOR V; FERREDOXIN-NADP REDUCTASE; GENE FREQUENCY; HOMOCYSTEINE; HUMANS; INFANT; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; RISK FACTORS; TURKEY;

EID: 0035870971     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00226-2     Document Type: Article

References (21)

1. Stroke in children within a major metropolitan area: The surprising importance of intracerebral hemorrhage
2. Etiology of stroke in children
3. Cerebrovascular disorders of childhood
4. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C
5. Mutation in blood coagulation factor V associated with resistance to activated protein C
6. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis
7. Factor V 1691 G-A. Prothrombin 20210 G-A and methylene tetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct
8. Co-existence of two prothrombotic mutations Factor V 1691 G-A and prothrombin gene 20210 G-A and the risk of cerebral infarct in pediatric patients
9. Lipoprotein (a) and genetic polymorphisms of clotting Factor V, prothrombin, and methylene tetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood
10. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children
11. Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct
12. Risk for venous thrombosis: Prevalence, risk and interaction
13. Hyperhomocysteinemia: An independent risk factor for vascular disease
14. Hyperhomocysteinemia as a risk factor for deep vein thrombosis
15. A candidate genetic risk factor for vascular disease: A common mutation in methylene tetrahydrofolate reductase
16. Frequency of Factor V 1691 G-A mutation in Turkish population
17. A second common mutation in the methylene tetrahydrofolate reductase gene: An additional risk factor for neural tube defects
18. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD in patients with neural tube defects
19. A common variant in methionine synthase reductase combined with low cobalamin increases risk for spina bifida
20. A rapid screening method for the Factor V Arg 506-Gln mutation
21. Prothrombin gene 20210 G-A mutation in the Turkish population